pancreatobiliary disease necessary for EUS or EUS-FNA
Conditions
Interventions
use of antispasmodic drugs
no use of antispasmodic drugs
Sponsors
Hokkaido university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients aged 20 years and older (2)Patients necessary for EUS/EUS-FNA (3)Patients with informed consent for joining the present study
Exclusion criteria
Exclusion criteria: (1)Refusal to provide informed consent (2)Poor general status (performance status 4: completely disabled, cannot perform any self-care, and totally confined to the bed) (3)Younger than age 20 years (4)Incapability of insertion of echoendoscope (5)Severe heart or pulmonary dysfunction (6)Pregnancy (7)Use of antispasmodic drugs (within 12 h) before EUS/EUS-FNA (8)Patients with bleeding tendency (9)Patients with hemorrhagic colitis, glaucoma, benign prostat hyperplasia, paralytic ileus, pheocromocytoma or allergy for butylscoporamine or glucagon (10)Judged inappropriate by a doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total examination time | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)Vital signs before, during and after EUS/EUS-FNA (2)Dose of sedative drugs (3)10 point VAS score for endoscopists and (4)patients satisfaction in EUS/EUS-FNA (5)Number of puncture and rate of aquisition of specimen in EUS-FNA (6)Dose of additive antispasmodic drugs | — |
Countries
Japan
Outcome results
None listed